The FDA has said on its website that it based its decision on the effectiveness of the Pfizer drug, which reached 90.7% in preventing Covid-19 among children 5 to 11 years old.

Pharmaceutical giant Pfizer has announced it planned to submit a COVID-19 vaccine for children under the age of 5 to the Food and Drug Administration (FDA) of the United for emergency authorization.

Children age 5 to ... country's vaccine rollout 10 months ago, when scarcity of doses and capacity issues meant a painstaking wait for many Americans. The country now has ample supplies of the Pfizer ...

Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds ... the extra-contagious delta variant and to help keep kids ...

The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive ...

CDC states that already an estimated 97% of Americans have some level of immunity, from either vaccination or infection or ...

Pfizer announced Tuesday it took another step forward in its study of how the vaccine works on kids ages 5 to 11. Right now, the shot is only approved for anyone 12 and older. But that could change by ...

The Delaware State Police continues to investigate the fatal pedestrian hit-and-run crash that occurred on Harbeson Road last ...

If you peruse the list of upcoming Food Network programs, you might see a familiar name on the list of “Chopped” contestants.

GSK (GSK) is reportedly suing Pfizer (PFE) and partner BioNTech (BNTX) for patent infringement over the use of certain mRNA ...

GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and ...